Amniotic Membrane Wound Care Products in Tacoma, WA

CDC PLACES vs. JF: two files, not one brochure

Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 10.9% of adults in Tacoma have diagnosed diabetes — 1.1 points below the U.S. 12% figure. 9.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick amniotic membrane wound care against that mix.

Where Tacoma programs actually stall

• CDC PLACES (2023, crude) estimates 10.9% of adults in Tacoma have diagnosed diabetes — 1.1 points below the U.S. 12% figure. Adult obesity in Tacoma is 37.3% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. A CTP without offloading and serial measurements still fails JF review. Product is the last step, not the first.
• Washington State Department of Health publishes state chronic-disease context that clinics can cite in patient education. Pair that with FDA 361 labeling — homologous use, minimal manipulation — so marketing does not outrun the product's actual regulatory lane.
• Skin-substitute and CTP coverage has been rewritten multiple times at the MAC level. Washington practices billing Noridian Healthcare Solutions need current LCD/article IDs on the claim, not a distributor slogan about “advanced wound care.”

Uninsured mix and Medicare CTPs in the same building

America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Tacoma we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 10.9% of adults in Tacoma have diagnosed diabetes — 1.1 points below the U.S. 12% figure.

How we’d stand this up in clinic